Janus kinase inhibitor

Results: 11



#Item
1Myelofibrosis / Janus kinase inhibitor / Splenomegaly / Myeloproliferative neoplasm / Ruxolitinib / Medical diagnosis / Polycythemia vera

HAEMATOLOGY AUDIT TEMPLATE

Add to Reading List

Source URL: www.bcshguidelines.com

Language: English - Date: 2015-09-20 08:20:56
2Needham & Company 15th Annual Healthcare Conference John Scarlett, M.D. President & CEO, Geron Corporation April 12, 2016

Needham & Company 15th Annual Healthcare Conference John Scarlett, M.D. President & CEO, Geron Corporation April 12, 2016

Add to Reading List

Source URL: www.geron.com

Language: English - Date: 2016-04-17 19:35:18
3Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca

Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca

Add to Reading List

Source URL: www.novartis.ca

Language: English - Date: 2015-05-13 10:22:06
4Haematology Clinical Trials The Department of Haematology at Flinders Medical Centre has a Clinical Trials Unit for research into the diagnosis, monitoring, and treatment of haematological disorders. This includes both b

Haematology Clinical Trials The Department of Haematology at Flinders Medical Centre has a Clinical Trials Unit for research into the diagnosis, monitoring, and treatment of haematological disorders. This includes both b

Add to Reading List

Source URL: www.fcic.org.au

Language: English - Date: 2014-02-25 19:14:38
5ruxolitinib (as phosphate), 5mg, 15mg, & 20mg tablets (Jakavi®) SMC No[removed]Novartis Pharmaceuticals UK Ltd. 06 February 2015 The Scottish Medicines Consortium (SMC) has completed its assessment of the above produc

ruxolitinib (as phosphate), 5mg, 15mg, & 20mg tablets (Jakavi®) SMC No[removed]Novartis Pharmaceuticals UK Ltd. 06 February 2015 The Scottish Medicines Consortium (SMC) has completed its assessment of the above produc

Add to Reading List

Source URL: www.scottishmedicines.org.uk

Language: English
6Combination therapy using JAK2 and HSP90 inhibitors increased efficacy in myelofibrosis in vivo

Combination therapy using JAK2 and HSP90 inhibitors increased efficacy in myelofibrosis in vivo

Add to Reading List

Source URL: medicalxpress.com

Language: English - Date: 2015-03-04 03:17:09
7第55回大河内賞 大河内記念生産賞 受賞 ~コークス炉診断・補修技術の開発~

第55回大河内賞 大河内記念生産賞 受賞 ~コークス炉診断・補修技術の開発~

Add to Reading List

Source URL: www.astellas.com

Language: English - Date: 2012-10-01 03:52:21
8Format 1 – Sample Bullet Slide

Format 1 – Sample Bullet Slide

Add to Reading List

Source URL: www.geron.com

Language: English - Date: 2014-11-18 07:05:07
9Pediatric Phase I / Pilot Consortium Malcolm A. Smith, MD, PhD Cancer Therapy Evaluation Program November 2011  Pediatric Phase I / Pilot Consortium –

Pediatric Phase I / Pilot Consortium Malcolm A. Smith, MD, PhD Cancer Therapy Evaluation Program November 2011 Pediatric Phase I / Pilot Consortium –

Add to Reading List

Source URL: deainfo.nci.nih.gov

Language: English - Date: 2011-11-14 10:42:10
101  Pharmacotherapy JAK inhibitors in myeloproliferative neoplasms

1 Pharmacotherapy JAK inhibitors in myeloproliferative neoplasms

Add to Reading List

Source URL: www.mpnresearchfoundation.org

Language: English - Date: 2011-09-13 08:25:55